Designing Growth Strategies is in our DNA

Genitourinary Drugs Market Size, Share & Industry Analysis By Drug Class (Androgen Receptor Pathway Inhibitors, GnRH Agonists/GnRH Antagonists, and Others), By Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia (BPH), Erectile Dysfunction, and Others), By Age Group (Pediatric, Adult, and others), By Type (Branded and Generics), By Route of Administration (Oral, Vaginal, Injectable/Parenteral, Topical/Transdermal, and Others), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated :May 8, 2026 | Format:PDF | Report ID: 116092

 

Request Sample PDF

man icon
Mail icon
Captcha refresh
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 190